Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,548 | 471 | 99.8% |
| Education | $10.02 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $716.73 | 66 | $0 (2022) |
| Amgen Inc. | $651.44 | 41 | $0 (2022) |
| Novo Nordisk Inc | $638.03 | 46 | $0 (2023) |
| PFIZER INC. | $583.87 | 48 | $0 (2023) |
| ABBVIE INC. | $465.30 | 35 | $0 (2024) |
| Astellas Pharma US Inc | $449.73 | 29 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $393.12 | 31 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $300.62 | 19 | $0 (2023) |
| GlaxoSmithKline, LLC. | $236.01 | 14 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $227.64 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.79 | 9 | Abbott Laboratories ($60.74) |
| 2023 | $736.48 | 51 | ABBVIE INC. ($234.54) |
| 2022 | $727.10 | 50 | ABBVIE INC. ($148.91) |
| 2021 | $743.59 | 50 | Novo Nordisk Inc ($121.31) |
| 2020 | $547.68 | 37 | Janssen Pharmaceuticals, Inc ($86.04) |
| 2019 | $854.85 | 62 | Janssen Pharmaceuticals, Inc ($115.67) |
| 2018 | $1,196 | 95 | Novo Nordisk Inc ($205.61) |
| 2017 | $1,588 | 119 | Amgen Inc. ($277.65) |
All Payment Transactions
473 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Diabetes Care | ||||||
| 07/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Diabetes Care | ||||||
| 04/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Biological | ||||||
| 04/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Diabetes Care | ||||||
| 02/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Biological | ||||||
| 01/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Biological | ||||||
| 12/12/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Oncology | ||||||
| 11/13/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Diabetes Care | ||||||
| 11/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes | ||||||
| 10/24/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Oncology | ||||||
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Respiratory | ||||||
| 10/18/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 1,826 | 2,867 | $145,261 | $91,550 |
| 2022 | 33 | 1,979 | 3,195 | $160,718 | $99,730 |
| 2021 | 37 | 2,663 | 4,572 | $182,878 | $118,192 |
| 2020 | 31 | 2,644 | 4,278 | $173,154 | $101,311 |
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 575 | $69,320 | $43,742 | 63.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 195 | $16,675 | $11,213 | 67.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 54 | $9,210 | $5,239 | 56.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $5,500 | $5,135 | 93.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 156 | 216 | $5,400 | $2,834 | 52.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 161 | 238 | $4,760 | $2,463 | 51.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 81 | 121 | $4,235 | $1,992 | 47.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 31 | 44 | $2,640 | $1,736 | 65.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 47 | 47 | $1,945 | $1,552 | 79.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 56 | $1,670 | $1,552 | 92.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,435 | $1,362 | 94.9% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 38 | 38 | $1,330 | $1,273 | 95.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 100 | 161 | $2,415 | $1,225 | 50.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 71 | 116 | $2,320 | $1,104 | 47.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 43 | 52 | $2,025 | $1,020 | 50.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 22 | 24 | $1,080 | $973.20 | 90.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 22 | 27 | $1,835 | $934.73 | 50.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 87 | $1,365 | $806.40 | 59.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 33 | 33 | $1,485 | $624.36 | 42.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 18 | 20 | $900.00 | $580.20 | 64.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 126 | 190 | $572.00 | $560.56 | 98.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 15 | $750.00 | $560.40 | 74.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 55 | 65 | $1,300 | $538.85 | 41.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 14 | $700.00 | $473.20 | 67.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 24 | $840.00 | $389.28 | 46.3% |
About Dr. Rodney Griffin, MD
Dr. Rodney Griffin, MD is a Family Medicine healthcare provider based in Magnolia, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023018439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodney Griffin, MD has received a total of $6,558 in payments from pharmaceutical and medical device companies, with $163.79 received in 2024. These payments were reported across 473 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,548).
As a Medicare-enrolled provider, Griffin has provided services to 9,112 Medicare beneficiaries, totaling 14,912 services with total Medicare billing of $410,783. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Magnolia, AR
- Active Since 07/28/2005
- Last Updated 06/19/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023018439
Products in Payments
- XARELTO (Drug) $552.27
- ELIQUIS (Drug) $443.32
- XIFAXAN (Drug) $259.21
- Ozempic (Drug) $255.94
- Prolia (Biological) $255.21
- UBRELVY (Drug) $245.22
- Victoza (Drug) $243.88
- ENTRESTO (Drug) $180.82
- TOUJEO (Drug) $179.18
- MYRBETRIQ (Drug) $166.30
- JANUVIA (Drug) $164.77
- INVOKANA (Drug) $164.46
- EVENITY (Biological) $150.90
- ANORO (Drug) $142.72
- Myrbetriq (Drug) $141.93
- Repatha (Biological) $134.32
- FREESTYLE LIBRE 3 (Device) $126.79
- SOLIQUA (Drug) $123.47
- VRAYLAR (Drug) $122.62
- TRULICITY (Drug) $114.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Magnolia
Feras Elhajj, Md, MD
Family Medicine — Payments: $54,053
Dr. Christian Edward Dyhianto, M.d, M.D
Family Medicine — Payments: $20,213
Dr. Ashley Chin, M.d, M.D
Family Medicine — Payments: $17,939
Matthew Barnett, Md, MD
Family Medicine — Payments: $8,629
Christine Gavino, D.o, D.O
Family Medicine — Payments: $5,148
Dr. Ked Davis, M.d, M.D
Family Medicine — Payments: $4,093